SCHEMBL25793933

SCHEMBL25793933

CCc1ccc(C(C)(C)C)cc1/C=C(\C)N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
RECQL P46063 1/20 0.36
SCN10A Q9Y5Y9 4/20 0.35
LRRK2 Q5S007 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP2D6 P10635 2/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
ESR1 P03372 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23816601 0.78 CYP1A2 (0.42) MAPTSMN1; SMN2CYP1A2CYP2C19ALDH1A1
SCHEMBL9505783 0.71 ALDH1A1 (0.55) MAPTCYP1A2CYP2C19ALDH1A1MEN1
Methylamine SCHEMBL28262977 0.71 CYP1A2 (0.46) MAPTCYP1A2CYP2C19ALDH1A1MEN1
SCHEMBL5167762 0.70 ALDH1A1 (0.59) MAPTSMN1; SMN2CYP1A2CYP2C19ALDH1A1
SCHEMBL28539089 0.67 CYP1A2 (0.42) MAPTCYP1A2CYP2C19ALDH1A1MEN1
SCHEMBL11546049 0.66 CYP1A2 (0.44) MAPTSMN1; SMN2CYP1A2CYP2C19ALDH1A1
SCHEMBL1229448 0.66 ESR1 (0.71) MAPTSMN1; SMN2CYP1A2CYP2C19ALDH1A1
SCHEMBL11511323 0.66 ALDH1A1 (0.48) MAPTCYP1A2CYP2C19ALDH1A1MEN1
SCHEMBL10235441 0.66 CYP2C19 (0.47) SMN1; SMN2CYP1A2CYP2C19ALDH1A1GAA
SCHEMBL10162939 0.66 EPHX2 (0.45) CYP1A2CYP2C19ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 MAPT 1665/4885SMN1; SMN2 342/4885CYP1A2 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.